搜尋結果
Evercore ISI says three years of biotech underperformance may be ending, gives its 5 favorite stocks
CNBC· 19 小時前The outlook on biotechnology is finally turning positive, according to Evercore ISI, which ...
Opinion | Now is the time to talk about vaccines, but Covid-19 leaves polarising legacy
South China Morning Post· 22 小時前Other drug makers such as BioNTech and Serum Institute have also faced lawsuits in Germany and ...
Evonik expects Q2 core profit in line with Q1, confirms 2024 outlook
Reuters· 7 日前Evonik said it expects its second-quarter core profit to be "on a par" with the first ...